Seminari di Ematologia Oncologica - Società Italiana di Ematologia

transplantation in 22 adult patients with lymphoblastic
lymphoma responsive to conventional
dose chemotherapy. Bone Marrow Transplant.
1992; 10: 33-8.
52. Verdonck LF, Dekker AW, de Gast GC, Lokhorst HM,
Nieuwenhuis HK. Autologous bone marrow transplantation
for adult poor-risk lymphoblastic lymphoma in
first remission. J Clin Oncol. 1992; 10: 644-6.
53. Jost LM, Jacky E, Dommann-Scherrer C, Honegger
HP, Maurer R, Sauter C, et al. Short-term weekly
chemotherapy followed by high-dose therapy with
autologous bone marrow transplantation for lymphoblastic
and Burkitt’s lymphomas in adult patients.
Ann Oncol. 1995; 6: 445-51.
54. Zinzani PL, Bendandi M, Visani G, Gherlinzoni F, Frezza
Linfoma linfoblastico dell’adulto
G, Merla E, et al. Adult lymphoblastic lymphoma: clinical
features and prognostic factors in 53 patients. Leuk
Lymphoma. 1996; 23: 577-82.
55. Bouabdallah R, Xerri L, Bardou VJ, Stoppa AM, Blaise
D, Sainty D, et al. Role of induction chemotherapy and
bone marrow transplantation in adult lymphoblastic
lymphoma: a report on 62 patients from a single center.
Ann Oncol. 1998; 9: 619-25.
56. Conde E, Zuazu J, Lopez-Guillermo A. Autologous
stem cell trasplant (ASCT) for lymphoblastic lymphoma
(LBL). [Abstract]. Blood. 1999; 94 (Suppl 1): 477a.
57. Aljurf M, Zaidi SZ. Chemotherapy and hematopoietic
stem cell transplantation for adult T-cell lymphoblastic
lymphoma: current status and controversies. Biol
Blood Marrow Transplant. 2005; 11: 739-54.
59